Buchumschlag

Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient

Weitere Versionen anzeigen (1)

Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of older patients with potentially toxic but active regimens like FOLFIRINO...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Berger, Anne Katrin (VerfasserIn) , Haag, Georg Martin (VerfasserIn) , Ehmann, Martin (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Springfeld, Christoph (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 December 2017
In: BMC gastroenterology
Year: 2017, Jahrgang: 17
ISSN:1471-230X
DOI:10.1186/s12876-017-0709-3
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12876-017-0709-3
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12876-017-0709-3
Volltext
Verfasserangaben:Anne Katrin Berger, Georg Martin Haag, Martin Ehmann, Anne Byl, Dirk Jäger, Christoph Springfeld
Beschreibung
Zusammenfassung:Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of older patients with potentially toxic but active regimens like FOLFIRINOX.
Beschreibung:Gesehen am 25.04.2018
Beschreibung:Online Resource
ISSN:1471-230X
DOI:10.1186/s12876-017-0709-3

Ähnliche Einträge